Novo Integrated Sciences, Inc. (NVOS)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 12.57 Million USD | 7.11% |
| 2022 | 11.73 Million USD | 26.14% |
| 2021 | 9.3 Million USD | 18.38% |
| 2020 | 7.86 Million USD | -16.57% |
| 2019 | 9.42 Million USD | 5.93% |
| 2018 | 8.89 Million USD | 11.7% |
| 2017 | 7.96 Million USD | 10.93% |
| 2016 | 7.17 Million USD | -3.85% |
| 2015 | 7.46 Million USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 3.15 Million USD | -0.59% |
| 2024 Q1 | 3.89 Million USD | 17.8% |
| 2024 Q2 | 3.17 Million USD | -18.52% |
| 2023 Q1 | 3.41 Million USD | 141.98% |
| 2023 Q4 | 3.3 Million USD | 0.31% |
| 2023 FY | 12.57 Million USD | 7.11% |
| 2023 Q3 | 3.29 Million USD | 28.81% |
| 2023 Q2 | 2.55 Million USD | -25.23% |
| 2022 FY | 11.73 Million USD | 26.14% |
| 2022 Q1 | 3.16 Million USD | 17.42% |
| 2022 Q4 | -8.14 Million USD | -158.8% |
| 2022 Q3 | 13.85 Million USD | 382.77% |
| 2022 Q2 | 2.86 Million USD | -9.26% |
| 2021 Q1 | 2.15 Million USD | 16.84% |
| 2021 Q3 | 2.38 Million USD | 14.7% |
| 2021 Q4 | 2.69 Million USD | 13.1% |
| 2021 FY | 9.3 Million USD | 18.38% |
| 2021 Q2 | 2.07 Million USD | -3.69% |
| 2020 FY | 7.86 Million USD | -16.57% |
| 2020 Q1 | 2.54 Million USD | 5.3% |
| 2020 Q2 | 2.42 Million USD | -4.7% |
| 2020 Q3 | 1.03 Million USD | -57.25% |
| 2020 Q4 | 1.84 Million USD | 77.69% |
| 2019 Q1 | 2.31 Million USD | 6.45% |
| 2019 FY | 9.42 Million USD | 5.93% |
| 2019 Q4 | 2.42 Million USD | -2.79% |
| 2019 Q2 | 2.2 Million USD | -4.81% |
| 2019 Q3 | 2.48 Million USD | 13.14% |
| 2018 FY | 8.89 Million USD | 11.7% |
| 2018 Q4 | 2.17 Million USD | -6.52% |
| 2018 Q3 | 2.32 Million USD | 8.26% |
| 2018 Q2 | 2.14 Million USD | -4.78% |
| 2018 Q1 | 2.25 Million USD | 1.51% |
| 2017 FY | 7.96 Million USD | 10.93% |
| 2017 Q4 | 2.22 Million USD | 6.24% |
| 2017 Q3 | 2.08 Million USD | 13.92% |
| 2017 Q2 | 1.83 Million USD | 0.91% |
| 2017 Q1 | 1.81 Million USD | -0.94% |
| 2016 FY | 7.17 Million USD | -3.85% |
| 2016 Q4 | 1.83 Million USD | -2.69% |
| 2016 Q1 | 1.72 Million USD | 0.0% |
| 2016 Q2 | 1.72 Million USD | -0.0% |
| 2016 Q3 | 1.88 Million USD | 9.13% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 FY | 7.46 Million USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.92 Billion USD | 99.571% |
| Addus HomeCare Corporation | 1.05 Billion USD | 98.812% |
| AirSculpt Technologies, Inc. | 195.91 Million USD | 93.583% |
| Amedisys, Inc. | 2.23 Billion USD | 99.438% |
| American Oncology Network, Inc. | 1.27 Billion USD | 99.017% |
| Astrana Health, Inc. | 1.38 Billion USD | 99.093% |
| Aveanna Healthcare Holdings Inc. | 1.89 Billion USD | 99.337% |
| IMAC Holdings, Inc. | 5.19 Million USD | -141.909% |
| biote Corp. | 185.36 Million USD | 93.218% |
| Cryo-Cell International, Inc. | 31.34 Million USD | 59.89% |
| Cross Country Healthcare, Inc. | 2.01 Billion USD | 99.378% |
| COMPASS Pathways plc | - USD | -Infinity% |
| DocGo Inc. | 624.28 Million USD | 97.986% |
| The Ensign Group, Inc. | 3.72 Billion USD | 99.663% |
| Healthcare Services Group, Inc. | 1.67 Billion USD | 99.248% |
| InnovAge Holding Corp. | 763.85 Million USD | 98.354% |
| Assure Holdings Corp. | 255 Thousand USD | -4830.204% |
| The Joint Corp. | 117.69 Million USD | 89.318% |
| LifeStance Health Group, Inc. | 1.05 Billion USD | 98.809% |
| Mobile-health Network Solutions Class A Ordinary Shares | 10.35 Million USD | -21.369% |
| ModivCare Inc. | 2.75 Billion USD | 99.543% |
| NewGenIvf Group Limited | 5.13 Million USD | -144.775% |
| Option Care Health, Inc. | 4.3 Billion USD | 99.708% |
| P3 Health Partners Inc. | 1.26 Billion USD | 99.007% |
| P3 Health Partners Inc. | 1.26 Billion USD | 99.007% |
| The Pennant Group, Inc. | 544.89 Million USD | 97.693% |
| Surgery Partners, Inc. | 2.74 Billion USD | 99.542% |
| Syra Health Corp. Class A Common Stock | 5.51 Million USD | -127.955% |
| Talkspace, Inc. | 150.04 Million USD | 91.621% |
| Talkspace, Inc. | 150.04 Million USD | 91.621% |
| The Oncology Institute, Inc. | 324.23 Million USD | 96.123% |
| The Oncology Institute, Inc. | 324.23 Million USD | 96.123% |